[{"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0356-2025", "product_description": "Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41", "product_quantity": "4956 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "A240467B, exp. date 07/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078427"], "brand_name": ["CETIRIZINE HCL"], "generic_name": ["CETIRIZINE"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "product_ndc": ["72657-128", "72657-129", "72657-130", "72657-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014676", "1014678"], "spl_id": ["9b19f466-3796-44b8-a637-092926c275f1"], "spl_set_id": ["04b08c52-5390-4cdb-a9e7-fca81fffdc73"], "package_ndc": ["72657-128-30", "72657-128-45", "72657-128-60", "72657-128-70", "72657-128-90", "72657-128-08", "72657-128-14", "72657-128-15", "72657-128-18", "72657-128-24", "72657-128-03", "72657-128-35", "72657-128-04", "72657-128-81", "72657-128-82", "72657-128-84", "72657-128-86", "72657-128-41", "72657-129-30", "72657-129-45", "72657-129-60", "72657-129-70", "72657-129-90", "72657-129-08", "72657-129-14", "72657-129-15", "72657-129-18", "72657-129-24", "72657-129-03", "72657-129-35", "72657-129-04", "72657-129-81", "72657-129-82", "72657-129-84", "72657-129-86", "72657-129-41", "72657-130-05", "72657-131-89"], "is_original_packager": [true], "upc": ["0372657128353", "0372657129350"], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0348-2025", "product_description": "Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Distributed by: Amazon. NDC# 72657-129-35", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231980, ep.. date Aug-25 Amazon 17232044, ep.. date Aug-25 Walmart  17241436, ep.. date Jul-26 Amazon 17241437, ep.. date Jul-26 Amazon 17241455, ep.. date Jul-26 Amazon 17241456, ep.. date Aug-26 Amazon 17241457, ep.. date Aug-26 Amazon 17241892, ep.. date Oct-26 Amazon 17241893, ep.. date Oct-26 Amazon"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97183", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0536-2025", "product_description": "Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.", "product_quantity": "2,890 vials", "reason_for_recall": "Sub-Potent Drug: Subpotent assay results during stability testing.", "recall_initiation_date": "20250709", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 25MAR032, Exp. 07/16/2025."}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97540", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0646-2025", "product_description": "bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226", "product_quantity": "109,320 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250829", "center_classification_date": "20250912", "report_date": "20250924", "code_info": "Lot #: C274-000044756, C274-000044757, Exp 8-30-2025; C274-000044832, C274-000044833, Exp 9-4-2025; C274-000044882, C274-000044883, Exp 9-6-2025, C274-000044972, Exp 9-8-2025; C274-000045004, C274-000045005, Exp 9-18-2025 C274-000045108, exp. date 9-13-2025 C274-000045109, exp. date 9-13-2025 C274-000045136, exp. date 9-14-2025 C274-000045137, exp. date 9-14-2025 C274-000045289, exp. date 9-20-2025 C274-000045290, exp. date 9-20-2025 C274-000045350, exp. date 9-22-2025 C274-000045351, exp. date 9-22-2025 C274-000045387, exp. date 9-25-2025 C274-000045388, exp. date 9-25-2025 C274-000045516, exp. date 9-27-2025 C274-000045517, exp. date 9-27-2025 C274-000045586, exp. date 10-2-2025 C274-000045587, exp. date 10-2-2025 C274-000045676, exp. date 10-4-2025 C274-000045677, exp. date 10-4-2025 C274-000045707, exp. date 10-5-2025 C274-000045708, exp. date 10-5-2025 C274-000045754, exp. date 10-9-2025 C274-000045755, exp. date 10-9-2025 C274-000045840, exp. date 10-11-2025 C274-000045841, exp. date 10-11-2025 C274-000046048, exp. date 10-24-2025 C274-000046049, exp. date 10-24-2025 C274-000046095, exp. date 10-25-2025 C274-000046096, exp. date 10-25-2025 C274-000046122, exp. date 10-26-2025 C274-000046123, exp. date 10-26-2025 C274-000046164, exp. date 10-30-2025 C274-000046165, exp. date 10-30-2025 C274-000046191, exp. date 10-31-2025 C274-000046192, exp. date 10-31-2025 C274-000046240, exp. date 11-1-2025 C274-000046241, exp. date 11-1-2025 C274-000046315, exp. date 11-6-2025 C274-000046316, exp. date 11-6-2025 C274-000046345, exp. date 11-7-2025 C274-000046346, exp. date 11-7-2025 C274-000046515, exp. date 11-14-2025 C274-000046516, exp. date 11-14-2025 C274-000046603, exp. date 11-16-2025 C274-000046657, exp. date 11-20-2025 C274-000047136, exp. date 12-12-2025"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0438-2025", "product_description": "Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-03", "product_quantity": "616,160 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0014, B0015, B0022, B0023, Exp Date: 05/31/2026; Lot B0024, B0025, B0026, B0027, B0033, B0034, B0035, B0039, B0040, B0041, B0045, Exp Date: 06/30/2026; Lot B0046, Exp Date: 07/31/2026"}, {"status": "Ongoing", "city": "Foster City", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208341"], "brand_name": ["SOFOSBUVIR AND VELPATASVIR"], "generic_name": ["VELPATASVIR AND SOFOSBUVIR"], "manufacturer_name": ["Asegua Therapeutics LLC"], "product_ndc": ["72626-2701"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOFOSBUVIR", "VELPATASVIR"], "rxcui": ["1799212"], "spl_id": ["314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d"], "spl_set_id": ["d0c1a945-4440-4b5c-81aa-693ed3db597c"], "package_ndc": ["72626-2701-1"], "is_original_packager": [true], "nui": ["N0000191493", "N0000191258", "N0000191256", "N0000190113", "N0000185503", "N0000190107", "N0000190108", "N0000190109"], "pharm_class_epc": ["Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "Hepatitis C Virus NS5A Inhibitor [EPC]"], "pharm_class_moa": ["RNA Replicase Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]"], "unii": ["WJ6CA3ZU8B", "KCU0C7RS7Z"]}, "product_type": "Drugs", "event_id": "96434", "recalling_firm": "ASEGUA THERAPEUTICS LLC", "address_1": "333 Lakeside Dr", "address_2": "N/A", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0313-2025", "product_description": "Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1", "product_quantity": "18,541 cartons.", "reason_for_recall": "Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.", "recall_initiation_date": "20250307", "center_classification_date": "20250407", "report_date": "20250416", "code_info": "Lot# 24ASV002UA, Exp Date: 6/30/2028"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204637"], "brand_name": ["AZELAIC ACID"], "generic_name": ["AZELAIC ACID"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-626"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["AZELAIC ACID"], "rxcui": ["1041518"], "spl_id": ["28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6"], "spl_set_id": ["0b5ab22e-c78a-4429-9a76-a4ba2d11fcde"], "package_ndc": ["68462-626-52"], "is_original_packager": [true], "upc": ["0368462626528"], "nui": ["N0000008841", "N0000009982"], "pharm_class_pe": ["Decreased Protein Synthesis [PE]", "Decreased Sebaceous Gland Activity [PE]"], "unii": ["F2VW3D43YT"]}, "product_type": "Drugs", "event_id": "97619", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0662-2025", "product_description": "Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52", "product_quantity": "13824 tubes", "reason_for_recall": "CGMP Deviations: Market complaints received for gritty texture (grainy)", "recall_initiation_date": "20250917", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Batch # 19252524, Exp Date: May 2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0668-2025", "product_description": "edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 oz (201g) Uptown Medi Spa, Phoenix, AZ.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0480-2025", "product_description": "Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "164 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #: C03035J, Exp 7/3/2025, H202959, exp 7/6/2025; AB20N110720 , exp 7/7/2025 ; AB60N1121, exp 7/7/2025; PRX022225-1 , exp 8/24/2025 ; U122024 , exp 10/26/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Newmarket", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95655", "recalling_firm": "Brands International Corporation", "address_1": "594 Newpark Blvd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0205-2025", "product_description": "Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By: Brands International Corp., Newmarket, ON, L3X 2S2. UPC 6 72008 80925 3", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviations: lack of adequate release testing.", "recall_initiation_date": "20241113", "center_classification_date": "20250117", "report_date": "20250129", "code_info": "Lots: 23319025, 23318024, 23313023, 23311022, 23310021, 23222021, 23220020, 23215019, 23215018, 23214017, 23213016, 23208015, 2313014, 2312213, 2312212, 2312111, 2312110, 2311709, 2311708, 2311607, 2311506, 2311405, 2307904, 23073003, 23072002, 2306901 and 24135003.  All expiration dates within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0236-2025", "product_description": "Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30.", "product_quantity": "87,600 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234153, Exp.: 9/2025; 19234900, 19234929, Exp.: 11/2025; 19240936, 19240942, Exp.: 2/2026; 19243199, 19243190, Exp.:7/2026; 19244013, 19244014, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0514-2025", "product_description": "GreenScreen, kabana organic skincare, Bread Spectrum UVA & UVB, Zinc Oxide Sunscreen, Organic Ingredients, Fragrance Free, Biodegradable, Chemical Free, Non-Nano, Baby Safe, Original, SPF 32, Totally Green personal care, Zinc Oxide USP 25%, 3.4 FL OZ/115 G Tube, NDC: 73369-0001-1", "product_quantity": "174 tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lots: 405-002 and 405-003", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96033", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0202-2025", "product_description": "glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11", "product_quantity": "2,028 units (cartons of 30 individual unit doses)", "reason_for_recall": "Failed Dissolution Specifications:", "recall_initiation_date": "20241217", "center_classification_date": "20250116", "report_date": "20250122", "code_info": "Lot # 1012910, Exp Date: 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Durham", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97382", "recalling_firm": "Haleon US Holdings LLC", "address_1": "3169 Route 145", "address_2": "N/A", "postal_code": "12423-1416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0592-2025", "product_description": "Sensodyne PRONAMEL (Potassium nitrate 5%, Sodium fluoride 0.25%) Active SHIELD Toothpaste for Sensitive Teeth, Fresh Mint, Net WT 3.4OZ (96.4g) Tube, 6 tubes x 2 inners, per case, Distributed by GSK Consumer Healthcare, Warren, NJ 07059. UPC 3 10158 35691 2", "product_quantity": "46,692 tubes", "reason_for_recall": "Labeling: Label Mix-up: The outer carton is labelled Fresh Mint. The tube is labelled Cool Mint/Whitening. The toothpaste inside the tube is Fresh Mint as indicated on the outer carton", "recall_initiation_date": "20250805", "center_classification_date": "20250819", "report_date": "20250827", "code_info": "Lot # for Case: 5058RB, Exp. date: 08/31/2027 Lot # for Carton and Tube: NJ2A, Exp 08/31/2027"}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96573", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID", "recall_number": "D-0364-2025", "product_description": "CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.", "product_quantity": "477 bottles.", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20250131", "center_classification_date": "20250415", "report_date": "20250423", "code_info": "Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0484-2025", "product_description": "Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "4 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot: H388348", "more_code_info": ""}, {"status": "Ongoing", "city": "Naples", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078466"], "brand_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "generic_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-459", "68180-755", "68180-756", "68180-472", "68180-463", "68180-473", "68180-759", "68180-760", "68180-757", "68180-758"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "BENAZEPRIL HYDROCHLORIDE"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_id": ["53566d4f-ff40-4815-b922-3416cde56fb1"], "spl_set_id": ["968c611b-43a7-40f0-9ed3-aa67ee88364b"], "package_ndc": ["68180-755-01", "68180-755-02", "68180-755-03", "68180-756-01", "68180-756-02", "68180-756-03", "68180-459-01", "68180-459-02", "68180-459-03", "68180-472-01", "68180-472-02", "68180-472-03", "68180-463-01", "68180-463-02", "68180-463-03", "68180-473-01", "68180-473-02", "68180-473-03", "68180-759-01", "68180-759-02", "68180-759-03", "68180-760-01", "68180-760-02", "68180-760-03", "68180-757-01", "68180-757-02", "68180-757-03", "68180-758-01", "68180-758-02", "68180-758-03"], "is_original_packager": [true], "upc": ["0368180459019"], "unii": ["N1SN99T69T", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "97182", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "5801 Pelican Bay Blvd", "address_2": "Suite 500", "postal_code": "34108-2755", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0542-2025", "product_description": "Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.", "product_quantity": "7668 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027", "recall_initiation_date": "20250702", "center_classification_date": "20250728", "report_date": "20250806", "code_info": "Lot GB01616, expiration 2/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211082"], "brand_name": ["RANOLAZINE"], "generic_name": ["RANOLAZINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-319", "68462-320"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RANOLAZINE"], "rxcui": ["616749", "728231"], "spl_id": ["8872581f-53be-4bde-8d22-c6960f11e9d6"], "spl_set_id": ["0cf58732-c242-49b0-8e3f-248778b4458d"], "package_ndc": ["68462-319-60", "68462-319-05", "68462-320-60", "68462-320-05"], "is_original_packager": [true], "upc": ["0368462320600", "0368462319604"], "nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["A6IEZ5M406"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0335-2025", "product_description": "Ranolazine  Extended-Release Tablets  1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240040, exp. date Dec-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0350-2025", "product_description": "Pravastatin Sodium Tablets, USP, 80mg, a).90-count bottle (16714-570-01), b). 500-count bottle (NDC 16714-570-02), Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17221770, exp. date Aug-25 17221774, exp. date Aug-25 17231251, exp. date May-26 17231262, exp. date May-26 17232112, exp. date Sep-26 17232133, exp. date Sep-26"}, {"status": "Ongoing", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201991"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-1494"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["c83706bb-e844-4e62-b4f4-c48536ea707d"], "spl_set_id": ["0cd086d6-3ae2-476e-b93e-29055e67e8fc"], "package_ndc": ["50090-1494-3", "50090-1494-4", "50090-1494-0", "50090-1494-1", "50090-1494-2"], "original_packager_product_ndc": ["67877-159"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96313", "recalling_firm": "A-S Medication Solutions LLC", "address_1": "2401 Commerce Dr", "address_2": "N/A", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in U.S.", "recall_number": "D-0292-2025", "product_description": "METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.", "product_quantity": "411 180-count bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules.", "recall_initiation_date": "20250225", "center_classification_date": "20250321", "report_date": "20250402", "code_info": "Lot# 4260340; Exp.12/31/2025."}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["GOOD NEIGHBOR PHARMACY ALCOHOL ANTISEPTIC SKIN CLEANSER"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Amerisouce Bergen"], "product_ndc": ["46122-043"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["38529756-605f-f0c5-e063-6294a90aee23"], "spl_set_id": ["fc28cf11-afb9-4295-bee3-735ab10f6bbc"], "package_ndc": ["46122-043-78", "6122407007"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97385", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0604-2025", "product_description": "Good Neighbor Pharmacy, Alcohol Prep Pads, Distributed By AmeriSource Bergen, 1 West First Avenue, Conshohocken, PA 19428, Made in China: 100 eaches per box, 30 boxes per case, (3,000 eaches per case), NDC 46122-043-78.", "product_quantity": "66,000 pads", "reason_for_recall": "Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.", "recall_initiation_date": "20250707", "center_classification_date": "20250826", "report_date": "20250903", "code_info": "61224070074", "more_code_info": ""}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800", "0264-7802"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807633", "1807634", "1807639"], "spl_id": ["9fa9f6b4-63b5-4632-8104-37c3dd1ee8fa"], "spl_set_id": ["7f22c06b-6b4d-4b49-a4b2-d2169f2bd653"], "package_ndc": ["0264-7800-00", "0264-7800-10", "0264-7800-20", "0264-7802-00", "0264-7802-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "97368", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0586-2025", "product_description": "0.9% Sodium Chloride Injection USP, L 8000, 1000mL Excel Container, Rx Only, Sterile, nonpyrogenic, single dose container, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-7800-00.", "product_quantity": "23,100 containers", "reason_for_recall": "Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.", "recall_initiation_date": "20250804", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: J5C919, Exp. 08/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96391", "recalling_firm": "Chattem Inc", "address_1": "1715 W 38th St", "address_2": "", "postal_code": "37409-1248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0266-2025", "product_description": "Unisom, SleepMelts, Diphenhydramine HCl tablets, 25 mg, Nighttime Sleep-Aid, 4 x 8 blister packs per carton, Cherry flavor, Manufactured by Adare Pharmaceuticals, Inc., Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409, UPC # 0 41167 0014 0", "product_quantity": "180,696 cartons", "reason_for_recall": "CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.", "recall_initiation_date": "20250304", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot#  252807, Exp: 5/31/2025; 252808, Exp: 6/30/2025; 372560, Exp: 11/30/2025; 489576, 493447, Exp: 4/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0020-2026", "product_description": "Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: 25140249, Exp. Dec. 2026 Lot#: 25140247, Exp. Dec. 2026 Lot#: 24144999, Exp. Nov. 2026 Lot#: 24144942, Exp. Nov. 2026 Lot#: 24144845, Exp. Nov. 2026 Lot#: 24144713, Exp. Nov. 2026 Lot#: 24144652, Exp. Oct. 2026 Lot#: 24143898, Exp. Aug. 2026 Lot#: 24143412, Exp. Aug. 2026 Lot#: 24143582, Exp. Aug. 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Zagreb", "state": "N/A", "country": "Croatia", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96601", "recalling_firm": "Apipharma", "address_1": "Ulica Jeronima Kavanjina 26", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ", "recall_number": "D-0375-2025", "product_description": "Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ  UPC 3 858882 103534 and UPC 3 858882 101318", "product_quantity": "4,218 boxes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250409", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0634-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1131-1", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z306327, Exp Date 30-11-25; Z306748, Exp Date 30-11-25; Z401154, Exp Date 28-02-26; Z403738, Exp Date 31-05-26; Z405645, Exp Date 30-09-26"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96191", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0217-2025", "product_description": "Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.", "product_quantity": "247 blister packs", "reason_for_recall": "CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250124", "center_classification_date": "20250203", "termination_date": "20250717", "report_date": "20250212", "code_info": "Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0195-2025", "product_description": "Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.", "product_quantity": "14825 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-306-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0179-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters).", "product_quantity": "8,029 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #: 550174101, Exp. 01/31/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Nogales", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96914", "recalling_firm": "Umary-USA.com", "address_1": "243 W Crawford St", "address_2": "STE 40026", "postal_code": "85621-3208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide via internet.", "recall_number": "D-0492-2025", "product_description": "UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295", "product_quantity": "1,342 30-count bottles", "reason_for_recall": "Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.", "recall_initiation_date": "20250521", "center_classification_date": "20250624", "report_date": "20250625", "code_info": "All Lots; All Expiration Dates.", "more_code_info": ""}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "97276", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "N/A", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S Nationwide", "recall_number": "D-0552-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.", "product_quantity": "1,829 60-count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit", "recall_initiation_date": "20250715", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "Lot: 230836C, Exp.: 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97556", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0657-2025", "product_description": "Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.", "product_quantity": "4440 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20250904", "center_classification_date": "20250918", "report_date": "20250924", "code_info": "Lot E309377, Exp 11/30/2025"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0396-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-450-17", "product_quantity": "4,885 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2300044, Exp Date: 12/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "generic_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "manufacturer_name": ["PAI Holdings, LLC"], "product_ndc": ["0121-0775", "0121-1775", "0121-1550"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CODEINE PHOSPHATE", "GUAIFENESIN"], "rxcui": ["995868"], "spl_id": ["2175415b-f07e-50a6-e063-6394a90acabe"], "spl_set_id": ["88d0994c-4270-4408-8837-bd97510b2118"], "package_ndc": ["0121-0775-04", "0121-0775-08", "0121-0775-16", "0121-1775-05", "0121-1775-00", "0121-1775-10", "0121-1775-40", "0121-1550-10", "0121-1550-00", "0121-1550-40"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["495W7451VQ", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "96119", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0222-2025", "product_description": "Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16", "product_quantity": "4080 Bottles", "reason_for_recall": "Superpotent; sodium benzoate preservative", "recall_initiation_date": "20250107", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot number 4B07, Exp Date: 2026-OCT-31", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95853", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0161-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "163,883 bottles", "reason_for_recall": "CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot #  222205C, exp. date 11/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0563-2025", "product_description": "Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "190 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Oxnard", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96763", "recalling_firm": "Siddha Flower Essences, LLC.", "address_1": "2350 Eastman Ave Ste 107", "address_2": "N/A", "postal_code": "93030-7265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0410-2025", "product_description": "temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030  NDC 69779-020-01.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot#  S22-26424D; Exp 9/27/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95936", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0159-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01", "product_quantity": "3,888", "reason_for_recall": "CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20241211", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97684", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0001-2026", "product_description": "Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.", "product_quantity": "912 30-count bottles", "reason_for_recall": "Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity", "recall_initiation_date": "20250924", "center_classification_date": "20251002", "report_date": "20251008", "code_info": "Lot#: E409308, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Hyderabad", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA211020"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-862", "16571-863"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993541", "993557"], "spl_id": ["a047dcfb-9b8c-446e-815e-2ee800cc7b79"], "spl_set_id": ["e4f4d3fa-ddf6-4125-8486-8157efc095c1"], "package_ndc": ["16571-862-03", "16571-862-09", "16571-862-50", "16571-862-10", "16571-862-12", "16571-863-03", "16571-863-09", "16571-863-50", "16571-863-10"], "is_original_packager": [true], "upc": ["0316571862030", "0316571863037"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "97629", "recalling_firm": "Graviti Pharmaceuticals Private Limited", "address_1": "E & 621 Patancheru Mandal", "address_2": "Isnapur Village Rd; Survey No 621", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.", "recall_number": "D-0037-2026", "product_description": "Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.", "product_quantity": "46,512/30 count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications", "recall_initiation_date": "20250915", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Batch # BPB124341A, Exp date: 10/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["CURAD ALCOHOL PREP PADS"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-827"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["4139066c-97a1-6d62-e063-6394a90a76e7"], "spl_set_id": ["1ce3872e-2307-4a38-bd7d-7eb2b226cf3c"], "package_ndc": ["53329-827-60", "53329-827-36", "53329-827-30", "53329-827-29", "53329-827-40", "53329-827-09", "53329-827-33", "6122405000"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97385", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0601-2025", "product_description": "CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply, Contents: 5 boxes per Carton, 30 Boxes per Case, Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093, USA, Made in India, www.curad.com, 1-800-633-5463, NDC 53329-827-30", "product_quantity": "1,639,996 pads", "reason_for_recall": "Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.", "recall_initiation_date": "20250707", "center_classification_date": "20250826", "report_date": "20250903", "code_info": "61224050002", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0485-2025", "product_description": "Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "216 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot: C03065F", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0650-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC#: 60687-463-01 (Individual Dose NDC: 60687-463-11)", "product_quantity": "873 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot: 1021640, Exp 10/31/2026; 1022639, Exp 01/31/2027"}, {"status": "Ongoing", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96465", "recalling_firm": "Fruit Of The Earth, Inc.", "address_1": "1430 Avenue R", "address_2": "N/A", "postal_code": "75050-1605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0284-2025", "product_description": "CVS Health Concealing Acne Treatment Cream, CVS, 10% benzoyl peroxide, 1 oz (28 g), Distributed by: CVS Pharmacy, Inc", "product_quantity": "112045 tubes", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20250311", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 4970743A, Exp 3/31/2026; 9712793A,  Exp9/30/2026; 8363513B, Exp 12/31/2026; 1391304A, 5101574A, Exp 5/31/2027; 1292084A, 1292084B, 1292084C, Exp 7/31/2027; 2892384A, Exp 8/31/2027; 6203044A, 6203044B, Exp 10/31/2027; 2153564A, 2153564B, Exp 12/31/2027; 2163564A, Exp 1/31/2028"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209718"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450"], "spl_id": ["3d5d1f23-c639-3604-e063-6294a90ac606"], "spl_set_id": ["8fce3252-95f8-4428-9922-5ba308e20177"], "package_ndc": ["60687-423-11", "60687-423-21"], "original_packager_product_ndc": ["69238-1305"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "96117", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0201-2025", "product_description": "Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-11", "product_quantity": "4640 units", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20250107", "center_classification_date": "20250114", "report_date": "20250122", "code_info": "Lot #: 1018598, Exp. Date 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0451-2025", "product_description": "Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05.", "product_quantity": "18,696 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lot, expiry: Lots 19231107, 19231114, 19231152, Exp Feb-25; Lot 19234866, Exp Jan-26"}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M003"], "brand_name": ["70% ISOPROPYL RUBBING ALCOHOL"], "generic_name": ["ISOPROPYL RUBBING ALCOHOL"], "manufacturer_name": ["TOPCO ASSOCIATES LLC"], "product_ndc": ["36800-589"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["808520"], "spl_id": ["374cac07-0520-1ce9-e063-6294a90a6d2b"], "spl_set_id": ["9fbded5f-8dc1-4134-a711-48d1a581d874"], "package_ndc": ["36800-589-14", "36800-589-72", "36800-589-43", "36800-589-45"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97506", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0661-2025", "product_description": "TopCare Health 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202.  NDC:  36800-589-14", "product_quantity": "60 bottles", "reason_for_recall": "Cross Contamination with Other Products.", "recall_initiation_date": "20250825", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot 0662036; Exp Date 06/19/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205566"], "brand_name": ["FENOFIBRATE"], "generic_name": ["FENOFIBRATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-580", "68462-581", "68462-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FENOFIBRATE"], "rxcui": ["200311", "310288", "310289"], "spl_id": ["65523b48-95b4-4491-94cc-5c3c79ac41a8"], "spl_set_id": ["e7204052-02cf-4b38-835b-d8754c74b2cd"], "package_ndc": ["68462-580-01", "68462-581-01", "68462-582-01"], "is_original_packager": [true], "upc": ["0368462581018", "0368462580011", "0368462582015"], "nui": ["N0000175596", "N0000175375", "M0199111"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "pharm_class_cs": ["PPAR alpha [CS]"], "unii": ["U202363UOS"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0314-2025", "product_description": "Fenofibrate Capsules 67 mg, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-580-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230834, exp. date Mar-25 17230835, exp. date Mar-25"}, {"status": "Ongoing", "city": "Naples", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077912"], "brand_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-518", "68180-519", "68180-520"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LISINOPRIL"], "rxcui": ["197885", "197886", "197887"], "spl_id": ["1474b42e-df82-41d5-9cbd-ebe3c45dcc9d"], "spl_set_id": ["515f735c-5dba-43d9-8a58-97a319cafd56"], "package_ndc": ["68180-518-02", "68180-518-01", "68180-518-30", "68180-519-30", "68180-519-01", "68180-519-02", "68180-520-02", "68180-520-30", "68180-520-01"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "E7199S1YWR"]}, "product_type": "Drugs", "event_id": "97118", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "5801 Pelican Bay Blvd", "address_2": "Suite 500", "postal_code": "34108-2755", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Product was distributed nationwide within the United States.", "recall_number": "D-0532-2025", "product_description": "Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only,  Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01", "product_quantity": "58,968 bottles", "reason_for_recall": "Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.", "recall_initiation_date": "20250620", "center_classification_date": "20250717", "report_date": "20250723", "code_info": "Lot #: QA01081, Exp. Date April 2027"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204730"], "brand_name": ["FROVATRIPTAN SUCCINATE"], "generic_name": ["FROVATRIPTAN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-694"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FROVATRIPTAN SUCCINATE"], "rxcui": ["349462"], "spl_id": ["49e68dd9-06c7-4d54-afa9-9016ae0b6995"], "spl_set_id": ["03a58215-dba7-4f63-8b98-d74d054a574a"], "package_ndc": ["68462-694-97"], "is_original_packager": [true], "upc": ["0368462694978"], "unii": ["D28J6W18HY"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0322-2025", "product_description": "Frovatriptan Succinate Tablets 2.5mg, 9-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-694-97", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231352, exp. date Jun-25 17231649, exp. date Jul-25"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070184"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2203", "0093-2204"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311666", "311668"], "spl_id": ["8f208d35-b19b-40a1-b363-f44ff08ec3d6"], "spl_set_id": ["e15905e0-e0f6-4c8b-ac19-59724d6c4bf0"], "package_ndc": ["0093-2204-01", "0093-2204-05", "0093-2203-01", "0093-2203-05", "0093-2203-10"], "is_original_packager": [true], "upc": ["0300932204010", "0300932203013"], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "96919", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0473-2025", "product_description": "Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.", "product_quantity": "36612 cartons", "reason_for_recall": "Presence of foreign tablets/capsules.", "recall_initiation_date": "20250523", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot#: 5420094, Exp 09/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96446", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0296-2025", "product_description": "fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75", "product_quantity": "2,310 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250306", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot, expiry:  Lots 10140284, 10140285, 10140315, 10140316, exp 04/08/2025; Lot 10140510, exp 04/14/2025; Lot 10140916, exp 04/24/2025"}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M003"], "brand_name": ["70% ISOPROPYL RUBBING ALCOHOL"], "generic_name": ["ISOPROPYL RUBBING ALCOHOL"], "manufacturer_name": ["Kroger CO"], "product_ndc": ["30142-810"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["808520"], "spl_id": ["36bf5591-e5eb-4038-e063-6394a90ac03c"], "spl_set_id": ["b127bba1-ce0b-4142-8b7d-f12f062b0938"], "package_ndc": ["30142-810-72", "30142-810-43", "30142-810-45", "30142-810-14"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97506", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0660-2025", "product_description": "Kroger 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202.  NDC:  30142-810-14", "product_quantity": "1860 bottles", "reason_for_recall": "Cross Contamination with Other Products.", "recall_initiation_date": "20250825", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot 0662036; Exp. Date  06/19/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0564-2025", "product_description": "Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "176 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0513-2025", "product_description": "Erin's Faces, Mineral SPF 32, UVA/UVB Sunscreen, Broad Spectrum SPF 32, 25% Zinc Oxide, 3 FL OZ/ 85 mL per bottle, Made in USA for Erin's Faces, Millburn, NO 07041.  NDC:  73369-1401-1", "product_quantity": "54 tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lot: 410-002", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0198-2025", "product_description": "Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.", "product_quantity": "456 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0124002B Exp 09/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0474-2025", "product_description": "Methylcobalamin Injectable, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "5", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #: H228307, Exp 12/27/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96607", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "N/A", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0374-2025", "product_description": "Rocuronium Bromide 50 mg per 5mL (10mg per mL),  5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11", "product_quantity": "16,655 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Leaking/damaged syringes.", "recall_initiation_date": "20250331", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #:2530023, Exp.: 7/12/2025"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0630-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.  NDC: 70710-1129-1", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z403012, Exp Date 30-04-26; Z406657, Exp Date 30-11-26"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0637-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-050-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305456, Exp Date 31-10-25; Z401156, Exp Date 28-02-26; Z407306, Exp Date 30-11-26"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206937"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-443", "13668-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["2532159", "2532163"], "spl_id": ["f8d8c930-c8f9-4186-92fa-6f7a5dabe083"], "spl_set_id": ["dcebc7cf-6f95-4f7a-a22b-c7d2e0f04d74"], "package_ndc": ["13668-443-74", "13668-443-10", "13668-443-01", "13668-443-30", "13668-443-91", "13668-473-10", "13668-473-74", "13668-473-30", "13668-473-01", "13668-473-91", "13668-473-70"], "is_original_packager": [true], "upc": ["0313668443301", "0313668473308"], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "96983", "recalling_firm": "Torrent Pharma Inc.", "address_1": "106 Allen Rd Ste 305", "address_2": "N/A", "postal_code": "07920-3851", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0456-2025", "product_description": "Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)", "product_quantity": "972 Cartons", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.", "recall_initiation_date": "20250527", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot# BDX6K001; Exp. Date: 06/30/2025"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079175"], "brand_name": ["INDOMETHACIN"], "generic_name": ["INDOMETHACIN"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-411"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["INDOMETHACIN"], "rxcui": ["310992"], "spl_id": ["2539d4a3-4162-ab7e-e063-6394a90aae5e"], "spl_set_id": ["5a65b650-ea9b-4d0d-b62f-5971df1e62b4"], "package_ndc": ["68084-411-11", "68084-411-21"], "original_packager_product_ndc": ["10702-016"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["XXE1CET956"]}, "product_type": "Drugs", "event_id": "96898", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0454-2025", "product_description": "Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-411-21 (carton), NDC 68084-411-11 (blister card).", "product_quantity": "21 cartons", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250515", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot #: 1021950, Exp. 11/30/2026"}, {"status": "Ongoing", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203899"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["62175-320", "62175-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141"], "spl_id": ["cd76800b-78a7-47ad-9ffa-4088e7984104"], "spl_set_id": ["d7b66e13-00ed-48a9-a54a-8e474cc31d54"], "package_ndc": ["62175-320-46", "62175-320-43", "62175-322-46", "62175-322-43"], "is_original_packager": [true], "upc": ["0362175320469", "0362175322463"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "97778", "recalling_firm": "Lannett Company Inc.", "address_1": "1101 C Ave W", "address_2": "", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0096-2026", "product_description": "Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136.  NDC:  62175-322-46", "product_quantity": "46,848 90-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20251010", "center_classification_date": "20251022", "report_date": "20251029", "code_info": "Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A,  Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462179017", "0368462178010", "0368462189016", "0368462188019", "0368462190012"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["57Y76R9ATQ", "9TN87S3A3C"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0346-2025", "product_description": "Naproxen Sodium Tablets, USP, 550mg, 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-179-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231956, exp. date Aug-25"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091442"], "brand_name": ["BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION"], "generic_name": ["BRIMONIDINE TARTRATE AND TIMOLOL MALEATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0589"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BRIMONIDINE TARTRATE", "TIMOLOL MALEATE"], "rxcui": ["861635"], "spl_id": ["1b350584-a1be-e9a4-9c25-00ec1a8ee4b7"], "spl_set_id": ["268c3f6b-8798-7987-3b8c-7b7f560af5d7"], "package_ndc": ["60505-0589-1", "60505-0589-2", "60505-0589-3", "0036050505", "6050505892"], "is_original_packager": [true], "unii": ["4S9CL2DY2H", "P8Y54F701R"]}, "product_type": "Drugs", "event_id": "97561", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0676-2025", "product_description": "Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).", "product_quantity": "151,034 bottles", "reason_for_recall": "Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns", "recall_initiation_date": "20250905", "center_classification_date": "20250930", "report_date": "20251008", "code_info": "a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL)  b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)"}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97251", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0567-2025", "product_description": "Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037, NDC 61919-422-30", "product_quantity": "16 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250307", "center_classification_date": "20250804", "report_date": "20250813", "code_info": "Lot #: 02AU2406, Exp 01/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-195", "68462-196", "68462-197", "68462-198"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["a6e006b3-4256-4cbb-8ad1-b71f363430cd"], "spl_set_id": ["6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4"], "package_ndc": ["68462-195-90", "68462-195-05", "68462-196-90", "68462-196-05", "68462-197-90", "68462-197-05", "68462-198-90", "68462-198-05"], "is_original_packager": [true], "upc": ["0368462195901", "0368462198902"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0341-2025", "product_description": "Pravastatin Sodium Tablets, 20mg, a).500-count bottle (NDC# 68462-196-05), b). 90-count bottle (NDC# 68462-196-90), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230810, exp. date Mar-26 17230811, exp. date Mar-26 17230810, exp. date  Mar-26 17232501, exp. date Nov-26 17232502, exp. date Nov-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0450-2025", "product_description": "Carvedilol Tablets USP 12.5 mg, 500-Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.  NDC: 68462-164-05", "product_quantity": "84,048 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lot, Exp: Lots 19231899, 19231922, 19231927, 19231967, 19231979, Exp Apr-25; Lots 19232226, 19232234, 19232265, 1923227,1 Exp May-25; Lots 19232758, 19232759, 19232762, 19232788, Exp Jun-25"}, {"status": "Ongoing", "city": "Kennett Square", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97202", "recalling_firm": "Boothwyn Pharmacy LLC", "address_1": "221 Gale Ln", "address_2": "N/A", "postal_code": "19348", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0608-2025", "product_description": "Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy", "product_quantity": "186 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250709", "center_classification_date": "20250829", "report_date": "20250910", "code_info": "03202025@9 BUD 07/18/2025"}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0663-2025", "product_description": "ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of Skin Beverly Hills, CA 90210", "product_quantity": "125", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "96014", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0182-2025", "product_description": "Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05", "product_quantity": "136,181 bottles", "reason_for_recall": "Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20241216", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212969"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-520", "68462-521"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807888", "1807915"], "spl_id": ["ef160cca-85e2-440c-997f-0535914b4d3f"], "spl_set_id": ["0ef9de1a-b786-4b6c-a250-3f5ac532b16a"], "package_ndc": ["68462-520-01", "68462-520-05", "68462-520-10", "68462-521-90", "68462-521-01", "68462-521-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0328-2025", "product_description": "Metformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC 68462-521-90.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232088, exp. date Sep-25 17232093, exp. date Sep-25"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals", "Cardinal Health 107, LLC"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667", "55154-3363", "55154-7992", "55154-7993"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af", "c5f4a9a6-33bb-4e3a-a8ac-ca41e8355b40"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f", "41844c21-9e2a-4332-a8ff-9b71ae9032b0"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61", "55154-3363-0", "55154-7992-0", "55154-7993-0"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224", "0904-6665", "0904-6666", "0904-6667"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"], "upc": ["0055154799300", "0055154799201", "0055154336307"]}, "product_type": "Drugs", "event_id": "97777", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0031-2026", "product_description": "Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .", "recall_initiation_date": "20251010", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # M04989A [Bag], M04989 [Blister Pack], Exp Date: 02/2026; Lot # M05056A [Bag], M05056 [Blister Pack], Exp Date: 04/2026; Lot # M05150A [Bag], M05150 [Blister Pack], Exp Date: 07/2026; Lot # M05312A [Bag], M05312 [Blister Pack], and M05342A [Bag], M05342 [Blister Pack], Exp Date: 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0523-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17", "product_quantity": "4,921 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300076, Exp Date: 12/31/2025"}, {"status": "Ongoing", "city": "Thousand Oaks", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103353"], "brand_name": ["NEUPOGEN"], "generic_name": ["FILGRASTIM"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-209", "55513-530", "55513-546", "55513-924"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["727535", "727537", "727544", "727545", "1649944", "1649946", "1649963", "1649964"], "spl_id": ["cc41b9c3-f2de-416f-9396-acdc8dac69b9"], "spl_set_id": ["97cc73cc-b5b7-458a-a933-77b00523e193"], "package_ndc": ["55513-530-01", "55513-530-10", "55513-530-20", "55513-546-01", "55513-546-10", "55513-546-20", "55513-924-01", "55513-924-10", "55513-924-91", "55513-924-20", "55513-209-01", "55513-209-10", "55513-209-91", "55513-209-20"], "is_original_packager": [true], "upc": ["0355513530101", "0355513546102"], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96325", "recalling_firm": "Amgen, Inc.", "address_1": "1 Amgen Center Dr", "address_2": "N/A", "postal_code": "91320-1730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherlands, Poland, Spain/Andorra, Sweden, Finland, Switzerland/Liechtenstein, United Kingdom of Great Britain and Northern Ireland, Ireland, Denmark, Canada, Hong Kong, Philippines, Israel, Malaysia, Saudi Arabia, Gibraltar.", "recall_number": "D-0285-2025", "product_description": "Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-530-01 (vial), NDC 55513-530-10 (box).", "product_quantity": "313,620 Vials", "reason_for_recall": "Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.", "recall_initiation_date": "20250227", "center_classification_date": "20250318", "report_date": "20250326", "code_info": "Lot #: 1147300, 1147300A, Exp.: 2/28/2025; 1152064, Exp.:3/31/2025; 1154734, 1156806, Exp.: 8/31/2025; 1159109, Exp.: 10/31/2025; 1163909, Exp.: 2/28/2026; 1164631, Exp.: 5/31/2026; 1171366, 1182097, Exp.:8/31/2026; 1176114, Exp.: 2/28/2027; 1182094, Exp.:7/31/2027."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "96626", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA", "recall_number": "D-0361-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1", "product_quantity": "3144 bottles, pack size: 100's Count", "reason_for_recall": "CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit", "recall_initiation_date": "20250403", "center_classification_date": "20250410", "report_date": "20250416", "code_info": "Lot #: Z400069, Exp.: 12/31/2025"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205927"], "brand_name": ["PRASUGREL"], "generic_name": ["PRASUGREL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5185", "0378-5186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRASUGREL HYDROCHLORIDE"], "rxcui": ["855812", "855818"], "spl_id": ["9e234352-49b7-46e3-bc59-acf63e0a7a14"], "spl_set_id": ["41a4e332-6725-4cb7-940a-8291cf56cfe4"], "package_ndc": ["0378-5185-93", "0378-5186-93"], "is_original_packager": [true], "upc": ["0303785185932"], "unii": ["G89JQ59I13"]}, "product_type": "Drugs", "event_id": "96369", "recalling_firm": "MYLAN PHARMACEUTICALS INC", "address_1": "1311 Pineview Dr", "address_2": "N/A", "postal_code": "26505-3276", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0280-2025", "product_description": "Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications - low dissolution results", "recall_initiation_date": "20250225", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 3211073, 3211074, 3211075, Exp 4/30/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "97031", "recalling_firm": "Church & Dwight Inc", "address_1": "469 N Harrison St", "address_2": "", "postal_code": "08540-3510", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0506-2025", "product_description": "Orajel Baby, Cooling Swabs for Teething, Each Unit 0.007 fl oz (0.22 mL), NET 0.08 FL OZ (2.6 mL) TOTAL, 12 Single-Use Swabs per carton, Manufactured for Church & Dwight Co. Inc. Ewing. NJ 08328 USA. UPC CODE 3 10310 40000 2.", "product_quantity": "695,880 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.", "recall_initiation_date": "20250606", "center_classification_date": "20250703", "report_date": "20250709", "code_info": "All Lots.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0672-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01", "product_quantity": "11,909 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250179A, Exp Date:  06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["URODEL"], "generic_name": ["CANTHARIS, CLEMATIS, CUBEBA, ECHINACEA, RANUNCULUS BULBOSUS, SABAL SERRULATA, STAPHYSAGRIA, UVA URSI"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-406"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ARCTOSTAPHYLOS UVA-URSI LEAF", "CLEMATIS RECTA FLOWERING TOP", "DELPHINIUM STAPHISAGRIA SEED", "ECHINACEA ANGUSTIFOLIA", "LYTTA VESICATORIA", "PIPER CUBEBA FRUIT", "RANUNCULUS BULBOSUS", "SAW PALMETTO"], "spl_id": ["3bdf040f-d0a4-e6db-e063-6394a90aaf3f"], "spl_set_id": ["0427bbc9-f4cc-0eb6-e063-6294a90a7199"], "package_ndc": ["55758-406-30"], "is_original_packager": [true], "unii": ["3M5V3D1X36", "396421SP9F", "00543AP1JV", "VB06AV5US8", "3Q034RO3BT", "Z99L7429MA", "AEQ8NXJ0MB", "J7WWH9M8QS"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0384-2025", "product_description": "Urodel, Urinary Tract Infection Symptoms Relief, Homeopathic, 30 chewable tablets per bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-406-30", "product_quantity": "10,752 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: UDE-01, EXP: OCT 26"}, {"status": "Ongoing", "city": "Opa Locka", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97405", "recalling_firm": "World Perfumes Inc.", "address_1": "2360 Nw 150th St", "address_2": "N/A", "postal_code": "33054-2706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0622-2025", "product_description": "Iodo Blanco Iodides, First Aid Antiseptic, Mercury Free, Iodine 2%, First Aid Antiseptic, Contains 1 fl. oz (30 ml) per bottle, Distributed by: Essential Products, www.essentialproductsusa.com, NDC: 70242-109-01", "product_quantity": "3,900 bottles", "reason_for_recall": "Defective Container: broken or leaking bottles.", "recall_initiation_date": "20250213", "center_classification_date": "20250908", "report_date": "20250917", "code_info": "Lot 230619, Exp 06/30/2026"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076109"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-1003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["KETOROLAC TROMETHAMINE"], "spl_id": ["fb740a51-5459-3c22-949d-7e4c9142fe84"], "spl_set_id": ["d9a186ba-74a9-b6d4-1109-1e045ba1763e"], "package_ndc": ["60505-1003-1", "60505-1003-2"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "96954", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0494-2025", "product_description": "Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-2", "product_quantity": "87,840 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250528", "center_classification_date": "20250625", "report_date": "20250702", "code_info": "Batch TZ1236, Exp Date: 11/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA215256"], "brand_name": ["WEGOVY"], "generic_name": ["SEMAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-4501", "0169-4525", "0169-4505", "0169-4517", "0169-4524"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["SEMAGLUTIDE"], "rxcui": ["2553501", "2553506", "2553601", "2553603", "2553802", "2553803", "2553901", "2553903", "2554102", "2554104"], "spl_id": ["4b92e0b3-da0b-4c1a-a926-295b389a1a57"], "spl_set_id": ["ee06186f-2aa3-4990-a760-757579d8f77b"], "package_ndc": ["0169-4525-01", "0169-4525-14", "0169-4525-90", "0169-4525-94", "0169-4505-01", "0169-4505-14", "0169-4501-01", "0169-4501-14", "0169-4517-01", "0169-4517-14", "0169-4524-01", "0169-4524-14"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["53AXN4NNHX"]}, "product_type": "Drugs", "event_id": "96637", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC, SC, VA", "recall_number": "D-0393-2025", "product_description": "Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.", "product_quantity": "48 Cartons", "reason_for_recall": "Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.", "recall_initiation_date": "20250409", "center_classification_date": "20250428", "report_date": "20250507", "code_info": "Lot PZFDE06, Exp 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091232"], "brand_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-565"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157"], "spl_id": ["0e9925c8-d7f8-5cea-e063-6294a90a50a2"], "spl_set_id": ["a3ce752d-58df-363d-e053-2a95a90a5411"], "package_ndc": ["42291-565-28", "42291-565-84"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97542", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0007-2026", "product_description": "Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only,  Manufactured for AvKARE, Pulaski, TN 38478.  Carton NDC:  42291-565-84; Blister NDC:  42291-565-28", "product_quantity": "2192 cartons", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20250902", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # LF41138A; Exp 06/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209239"], "brand_name": ["SOLIFENACIN SUCCINATE"], "generic_name": ["SOLIFENACIN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-386", "68462-387"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOLIFENACIN SUCCINATE"], "rxcui": ["477367", "477372"], "spl_id": ["9cfcab1d-64ac-457b-979f-41cf6547a63a"], "spl_set_id": ["010c0657-c907-477f-8bd7-5d455a5f50eb"], "package_ndc": ["68462-386-30", "68462-386-90", "68462-386-14", "68462-387-30", "68462-387-90", "68462-387-14"], "is_original_packager": [true], "upc": ["0368462386309", "0368462387306"], "unii": ["KKA5DLD701"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0333-2025", "product_description": "Solifenacin Succinate Tablets 5mg, a.) 30-count bottle (NDC# 68462-386-30) b.) 90-count bottle (NDC# 68462-386-90), Rx Only. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "30 count bottle:  17232395, exp. date Nov-25 17232400, exp. date Nov-25  90-count bottle:  17232395, exp. date Nov-25"}, {"status": "Ongoing", "city": "Wilmington", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA214070"], "brand_name": ["AIRSUPRA"], "generic_name": ["ALBUTEROL SULFATE AND BUDESONIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-9080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE", "BUDESONIDE"], "rxcui": ["2665906", "2665912", "2678391", "2678392"], "spl_id": ["8738de51-e5d3-4ac5-910d-a155169ab78e"], "spl_set_id": ["e60aa9f9-5139-44df-b886-ebddc3c7eb13"], "package_ndc": ["0310-9080-12", "0310-9080-28"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["021SEF3731", "Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "96857", "recalling_firm": "AsttraZeneca Pharmaceuticals LP", "address_1": "1800 Concord Pike", "address_2": "N/A", "postal_code": "19897-0001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0444-2025", "product_description": "Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .", "product_quantity": "a) 807,837 canisters; b)  235,698 canisters", "reason_for_recall": "Defective delivery system", "recall_initiation_date": "20250514", "center_classification_date": "20250521", "report_date": "20250528", "code_info": "Lot#:  a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0199-2025", "product_description": "Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.", "product_quantity": "324 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDC0224001B Exp 09/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021537"], "brand_name": ["CIPROFLOXACIN AND DEXAMETHASONE"], "generic_name": ["CIPROFLOXACIN AND DEXAMETHASONE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-6186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE", "DEXAMETHASONE"], "rxcui": ["403908"], "spl_id": ["39a8b845-aa32-4c9d-bef8-18cea1ef7bc9"], "spl_set_id": ["89fef4d2-7078-47f1-96bf-aca50b135a97"], "package_ndc": ["0781-6186-67"], "is_original_packager": [true], "upc": ["0307816186677"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["4BA73M5E37", "7S5I7G3JQL"]}, "product_type": "Drugs", "event_id": "97431", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "N/A", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one consignee in CA.", "recall_number": "D-0626-2025", "product_description": "Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ,  NDC# 0781-6186-67, Carton NDC# 0781-6186-67", "product_quantity": "1,680 bottles", "reason_for_recall": "Temperature Abuse", "recall_initiation_date": "20250813", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot # VNF35A, Exp.08/31/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077662"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-126", "68462-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310433", "310434"], "spl_id": ["5c6de7e2-6f75-426a-a832-5cea5c70b43e"], "spl_set_id": ["3865a6e3-112c-490c-82ac-35401336b16e"], "package_ndc": ["68462-126-01", "68462-126-05", "68462-127-01", "68462-127-05"], "is_original_packager": [true], "upc": ["0368462127018", "0368462126011"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0320-2025", "product_description": "Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17231015, exp. date Apr-25 17231128, exp. date Apr-25 17231138, exp. date Apr-25 17231139, exp. date Apr-25 17231143, exp. date Apr-25 17231144, exp. date Apr-25 17231848, exp. date Aug-25 17231898, exp. date Aug-25 17231977, exp. date Aug-25 17231978, exp. date Aug-25 17232015, exp. date Aug-25 17232016, exp. date Aug-25 17232017, exp. date Aug-25 17232034, exp. date Aug-25 17232041, exp. date Aug-25 17232396, exp. date Nov-25 17232406, exp. date Nov-25 17232410, exp. date Nov-25 17232490, exp. date Nov-25 17240326, exp. date Jan-26 17240327, exp. date Jan-26 17240383, exp. date Feb-26 17240395, exp. date Feb-26 17241863, exp. date Oct-26 17241869, exp. date Oct-26 17241870, exp. date Oct-26 17231256, exp. date May-25 17231386, exp. date May-25 17231387, exp. date May-25 17231407, exp. date May-25 17231417, exp. date May-25 17231418, exp. date May-25 17231754, exp. date Jul-25 17240085, exp. date Dec-25 17240117, exp. date Dec-25 17240131, exp. date Dec-25"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M003"], "brand_name": ["PERIGIENE"], "generic_name": ["ANTIMICROBIAL DRUG PRODUCT"], "manufacturer_name": ["Dermarite Industries LLC"], "product_ndc": ["61924-198"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["436367", "1549631"], "spl_id": ["2888063b-6f40-9359-e063-6394a90a6a3c"], "spl_set_id": ["4f6e8610-f474-450e-a385-eaea58f649c8"], "package_ndc": ["61924-198-08", "61924-198-01"], "is_original_packager": [true], "upc": ["0714196198082"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0613-2025", "product_description": "PeriGiene, Health Care Antiseptic, (Chloroxylenol 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08", "product_quantity": "5,703 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot #: 31013A, Exp. Date 11/2025; 40345A, 40355A, Exp. Date 4/2026; 40571A, 40580A, Exp. Date 6/2026; 40587A, 40591A, Exp. Date 7/2026; 40870.1, 40877.1, Exp. Date 10/2026; 41093A, Exp. Date 12/2026; 50072A, 50079A, Exp. Date 1/2027"}, {"status": "Terminated", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210757"], "brand_name": ["COLCHICINE"], "generic_name": ["COLCHICINE"], "manufacturer_name": ["Granules Pharmaceutical Inc."], "product_ndc": ["70010-001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLCHICINE"], "rxcui": ["1550940"], "spl_id": ["3836b9fe-5628-fe23-e063-6294a90aa475"], "spl_set_id": ["16d49c45-5b0a-a7fa-e063-6294a90a7320"], "package_ndc": ["70010-001-01", "70010-001-10", "70010-001-03"], "is_original_packager": [true], "upc": ["0370010001039"], "nui": ["N0000193949", "M0000713"], "pharm_class_epc": ["Alkaloid [EPC]"], "pharm_class_cs": ["Alkaloids [CS]"], "unii": ["SML2Y3J35T"]}, "product_type": "Drugs", "event_id": "96026", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0187-2025", "product_description": "Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03", "product_quantity": "96 Bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.", "recall_initiation_date": "20241218", "center_classification_date": "20250107", "termination_date": "20250701", "report_date": "20250115", "code_info": "Lot#: GPC240763B, Exp. Date 6/17/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077857"], "brand_name": ["ENOXAPARIN SODIUM"], "generic_name": ["ENOXAPARIN SODIUM"], "manufacturer_name": ["Cardinal Health 107, LLC", "Sandoz Inc"], "product_ndc": ["55154-3540", "55154-3541", "55154-3542", "55154-3543", "55154-3544", "0781-3238", "0781-3246", "0781-3256", "0781-3262", "0781-3268", "0781-3298", "0781-3299"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["ENOXAPARIN SODIUM"], "rxcui": ["854228", "854235", "854238", "854241", "854248", "854245", "854252"], "spl_id": ["69a14cc6-8c40-4be6-a5eb-cd4f9def8abe", "82c50153-58b8-4c35-8fc2-1d9b3d3ac7de"], "spl_set_id": ["5e7568a6-cf8a-4de2-86ba-b94c8ab4c806", "38f60bd8-b518-4098-a808-b8f5a3ae6a3a"], "package_ndc": ["55154-3540-5", "55154-3541-5", "55154-3542-5", "55154-3543-5", "55154-3544-5", "0781-3238-01", "0781-3238-63", "0781-3246-02", "0781-3246-64", "0781-3256-03", "0781-3256-66", "0781-3262-04", "0781-3262-68", "0781-3268-05", "0781-3268-69", "0781-3298-04", "0781-3298-68", "0781-3299-05", "0781-3299-69"], "original_packager_product_ndc": ["0781-3238", "0781-3246", "0781-3256", "0781-3262", "0781-3268"], "upc": ["0055154354059", "0055154354455", "0055154354257", "0055154354158"], "unii": ["8NZ41MIK1O"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97380", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "KS", "recall_number": "D-0597-2025", "product_description": "Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01", "product_quantity": "10 bags", "reason_for_recall": "Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL", "recall_initiation_date": "20250805", "center_classification_date": "20250822", "report_date": "20250903", "code_info": "Outer package - NDC 55154-3543-5, Lot SAD08033AA   Inner label - NDC 0781-3238-01, Lot SAF13211A", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "96495", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0282-2025", "product_description": "Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05", "product_quantity": "90960 bottles", "reason_for_recall": "Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20250311", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot: 084A067, Exp 12/31/2025"}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["HYDROGEN PEROXIDE"], "generic_name": ["HYDROGEN PEROXIDE"], "manufacturer_name": ["Vi-Jon, LLC"], "product_ndc": ["0869-0871"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROGEN PEROXIDE"], "rxcui": ["91349"], "spl_id": ["3deb136a-9aee-4364-e063-6294a90a626f"], "spl_set_id": ["e0a07631-6770-48b3-bf7b-19f3f3965cd9"], "package_ndc": ["0869-0871-72", "0869-0871-43", "0869-0871-45", "0869-0871-18", "0869-0871-99", "0869-0871-82"], "is_original_packager": [true], "unii": ["BBX060AN9V"]}, "product_type": "Drugs", "event_id": "96475", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "VA", "recall_number": "D-0302-2025", "product_description": "[CORRECT FRONT PANEL] Hydrogen Peroxide Topical Solution, USP, 32 FL OZ (1 QT) 946 mL per bottle, NDC 0869-0871-45; [INCORRECT BACK LABEL] Isopropyl alcohol 91%, Dist. by: Amazon.com Services, LLC, Seattle, WA 98109.", "product_quantity": "25,932 bottles", "reason_for_recall": "Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol", "recall_initiation_date": "20250307", "center_classification_date": "20250327", "report_date": "20250402", "code_info": "Lot 0643188, exp. date 10/22/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA062831"], "brand_name": ["CEFAZOLIN"], "generic_name": ["CEFAZOLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-3450", "0781-3451"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "PARENTERAL"], "substance_name": ["CEFAZOLIN SODIUM"], "rxcui": ["1665050", "1665052"], "spl_id": ["5fa78ed4-14be-485c-9e36-fd46a19d18fb"], "spl_set_id": ["18e7366a-1b3e-4010-8f4a-dd559d4f2146"], "package_ndc": ["0781-3450-70", "0781-3450-95", "0781-3451-70", "0781-3451-96"], "is_original_packager": [true], "unii": ["P380M0454Z"]}, "product_type": "Drugs", "event_id": "97140", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0569-2025", "product_description": "Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).", "product_quantity": "208,300 vials", "reason_for_recall": "Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin", "recall_initiation_date": "20250627", "center_classification_date": "20250806", "report_date": "20250709", "code_info": "Lot # PG4360, PG4362, Exp. 11/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077242"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-137", "62756-138", "62756-139", "62756-202", "62756-204"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "spl_id": ["aff50a15-df39-495f-a145-0ba59660eed8"], "spl_set_id": ["c9a05f0c-b5f0-422c-9d67-6d0efc921a74"], "package_ndc": ["62756-137-02", "62756-137-03", "62756-137-05", "62756-137-04", "62756-137-01", "62756-138-02", "62756-138-03", "62756-138-05", "62756-138-04", "62756-138-01", "62756-139-02", "62756-139-03", "62756-139-05", "62756-139-04", "62756-139-01", "62756-202-01", "62756-202-03", "62756-204-01", "62756-204-03"], "is_original_packager": [true], "upc": ["0362756204010", "0362756202016", "0362756138025", "0362756137028", "0362756139022"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96415", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0312-2025", "product_description": "Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.", "product_quantity": "852 bottles", "reason_for_recall": "Cross Contamination", "recall_initiation_date": "20250304", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97370", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0578-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. NDC 68462-164-05", "product_quantity": "6,432 bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine,  N-Nitroso Carvedilol I  Impurity above the current Acceptable Intake Level.", "recall_initiation_date": "20250807", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot#:19243202, Exp: 7/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077653"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-018", "68382-019", "68382-020", "68382-021", "68382-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313580", "313582", "313584", "313586", "314277"], "spl_id": ["ea404f6c-7e07-4779-a52c-8cffb92718ef"], "spl_set_id": ["72efad5f-0909-46a5-aa13-ac24fe015fe6"], "package_ndc": ["68382-018-06", "68382-018-14", "68382-018-16", "68382-018-01", "68382-018-05", "68382-018-10", "68382-019-06", "68382-019-14", "68382-019-16", "68382-019-01", "68382-019-05", "68382-019-10", "68382-020-06", "68382-020-14", "68382-020-16", "68382-020-01", "68382-020-05", "68382-020-10", "68382-021-06", "68382-021-14", "68382-021-16", "68382-021-01", "68382-021-05", "68382-021-10", "68382-101-06", "68382-101-14", "68382-101-16", "68382-101-01", "68382-101-05", "68382-101-10"], "is_original_packager": [true], "upc": ["0368382019011", "0368382018014", "0368382021014", "0368382101013"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "96553", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide.", "recall_number": "D-0310-2025", "product_description": "Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.", "product_quantity": "13,128 100-Count Bottles", "reason_for_recall": "Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.", "recall_initiation_date": "20250321", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot #: M314265, Exp.: 31 October 2025."}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078203"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6007", "0904-6008", "0904-6009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LORAZEPAM"], "rxcui": ["197900", "197901", "197902"], "spl_id": ["6b6c2fbc-d12d-41d7-b49d-cf374c773cbd"], "spl_set_id": ["62f6eb3b-813d-4890-aca9-799b7fa890df"], "package_ndc": ["0904-6007-60", "0904-6007-61", "0904-6008-60", "0904-6008-61", "0904-6009-60", "0904-6009-61"], "original_packager_product_ndc": ["69315-904", "69315-905", "69315-906"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "96151", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide U.S. and Puerto rico", "recall_number": "D-0226-2025", "product_description": "Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61", "product_quantity": "82,281 cartons", "reason_for_recall": "Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.", "recall_initiation_date": "20250121", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026."}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0379-2025", "product_description": "DoloDent Maximum Strength Toothache Drops, Homeopathic Oral Drops, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-400-15", "product_quantity": "9504 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot EDD-01"}]